CVS Health比Q3收入估计数高10.9 EPS和954.3亿美元的收入。 CVS Health beat Q3 earnings estimates, with a $1.09 EPS and $95.43 billion in revenue.

美国CVS健康公司报告了强的第三季度收益, 超过分析师的预期, 收益每股1.09美元, 收入954亿美元. CVS Health reported strong Q3 earnings, beating analysts' estimates with $1.09 EPS and $95.43 billion in revenue. 机构投资者对其持有的股份作了重大改变,有些减少,另一些增加其利害关系。 Institutional investors made significant changes to their holdings, with some reducing and others increasing their stakes. 分析师意见不一, 评分从“坚持”到“超重”不等, 协商一致的目标价格为70.33美元。 Analysts have mixed views, with ratings ranging from "hold" to "overweight," and a consensus target price of $70.33. 该公司还将其股利提高到每股0.665美元。 The company also raised its dividend to $0.665 per share.